Single-dose Covid-19 Vaccine
- All
- News
- Videos
-
One-Shot Sputnik Light Vaccine Gets Emergency Use Approval In India
The Drugs Controller General of India (DCGI) has granted emergency-use permission to the single-dose Sputnik Light COVID-19 vaccine, informed Union Health Minister Mansukh Mandaviya on Sunday.
-
EU Lists Rare Spinal Condition As Johnson & Johnson Vaccine Side Effect
Europe's drug regulator on Thursday recommended adding a rare type of spinal inflammation called transverse myelitis as a side-effect of Johnson & Johnson's single-dose COVID-19 vaccine.
-
Dr Reddy's Hopes To Submit Sputnik V Light Trial Data To Drug Regulator In November
Dr Reddy's Laboratories Ltd is expected to submit Phase 3 trials data of single-dose Russian COVID-19 vaccine Sputnik Light to the Indian drug regulator next month, even as the city-based firm is getting ready to conduct trials of the jab in 2 to 18
-
Russia's Sputnik Light Vaccine 70% Effective Against Delta Variant: Report
Sputnik Light, Russia's single-dose COVID-19 vaccine, has been found to demonstrate 70 per cent efficacy against infection with the Delta variant during the first three months after vaccination.
-
Johnson & Johnson's Single-Dose Covid Vaccine Approved In India
Global healthcare major Johnson & Johnson's single-dose COVID-19 vaccine has received emergency use approval in India, Union Health Minister Mansukh Mandaviya tweeted.
-
Johnson & Johnson Applies For Emergency Use Approval Of Its Single-Dose COVID-19 Vaccine In India
Global healthcare major Johnson & Johnson today said it has applied for Emergency Use Authorisation (EUA) of its single-dose COVID-19 vaccine in India.
-
J&J Shot Performs Poorly Against Delta Variant
Johnson & Johnson's single-dose Covid vaccine produced relatively low levels of antibodies against delta variant in a study, raising questions about how well the shot will hold up against the strain that accounts for the vast majority of US cases.
-
188 Crore Covid Vaccine Doses Required To Inoculate 18-Plus Population: Centre
The 18-plus population in India is 94 crore and therefore, the total requirement of Covid vaccine doses for the beneficiaries in this age group is 188 crore, but the number may reduce if in future, single-dose vaccines are approved, the Centre said.
-
Single-Dose Sputnik Vaccine To Be Launched In India Soon: Russian Envoy
The single-dose Sputnik Light COVID-19 vaccine is expected to launch soon in India said Russian envoy Nikolay Kudashev on Wednesday.
-
India Will Accept 1-Dose Sputnik Light Trial Data From Russia: Dr Reddy's
A government expert panel has said that Sputnik Light can submit Phase 3 trial data for the single-dose Sputnik Light COVID-19 vaccine in India, its India-partner Dr Reddy's said on Thursday, hours after reports said they had been denied approval for
-
Cipla Close To Committing Over $1 Billion For Moderna Booster Vaccine In India: Report
Seeking fast-track approvals to bring Moderna's single-dose COVID-19 booster vaccine in India expeditiously, Cipla has requested the government for indemnification and exemptions from price capping, bridging trials and basic customs duty.
-
Centre Expects Speedy India Launch Of Single-Dose Sputnik Light: Report
The government is hopeful of a speedy launch of single-dose COVID-19 vaccine Sputnik Light in India and all stakeholders, including the Russian manufacturer and its Indian partners, have been directed to fast-track the application
-
Moderna, Pfizer Covid Vaccines Likely In India Next Year: Report
Moderna is expecting to launch a single-dose COVID-19 vaccine in India next year and is in talks with Cipla among other firms, while Pfizer is ready to offer 5 crore shots in 2021 but it wants significant regulatory relaxations.
-
J&J Seeks India's Permission For Phase 3 Trial Of 1-Shot Vaccine: Report
Multinational pharma giant Johnson & Johnson has applied to India's drug regulator seeking permission to conduct phase-3 clinical trial of its single-dose COVID-19 vaccine in India as well as import licence, sources said.
-
J&J Says In Talks With India For Clinical Study Of Single-Dose Vaccine
Johnson & Johnson says in talks with India to start early stage clinical study of its single-dose Covid vaccine
-
One-Shot Sputnik Light Vaccine Gets Emergency Use Approval In India
The Drugs Controller General of India (DCGI) has granted emergency-use permission to the single-dose Sputnik Light COVID-19 vaccine, informed Union Health Minister Mansukh Mandaviya on Sunday.
-
EU Lists Rare Spinal Condition As Johnson & Johnson Vaccine Side Effect
Europe's drug regulator on Thursday recommended adding a rare type of spinal inflammation called transverse myelitis as a side-effect of Johnson & Johnson's single-dose COVID-19 vaccine.
-
Dr Reddy's Hopes To Submit Sputnik V Light Trial Data To Drug Regulator In November
Dr Reddy's Laboratories Ltd is expected to submit Phase 3 trials data of single-dose Russian COVID-19 vaccine Sputnik Light to the Indian drug regulator next month, even as the city-based firm is getting ready to conduct trials of the jab in 2 to 18
-
Russia's Sputnik Light Vaccine 70% Effective Against Delta Variant: Report
Sputnik Light, Russia's single-dose COVID-19 vaccine, has been found to demonstrate 70 per cent efficacy against infection with the Delta variant during the first three months after vaccination.
-
Johnson & Johnson's Single-Dose Covid Vaccine Approved In India
Global healthcare major Johnson & Johnson's single-dose COVID-19 vaccine has received emergency use approval in India, Union Health Minister Mansukh Mandaviya tweeted.
-
Johnson & Johnson Applies For Emergency Use Approval Of Its Single-Dose COVID-19 Vaccine In India
Global healthcare major Johnson & Johnson today said it has applied for Emergency Use Authorisation (EUA) of its single-dose COVID-19 vaccine in India.
-
J&J Shot Performs Poorly Against Delta Variant
Johnson & Johnson's single-dose Covid vaccine produced relatively low levels of antibodies against delta variant in a study, raising questions about how well the shot will hold up against the strain that accounts for the vast majority of US cases.
-
188 Crore Covid Vaccine Doses Required To Inoculate 18-Plus Population: Centre
The 18-plus population in India is 94 crore and therefore, the total requirement of Covid vaccine doses for the beneficiaries in this age group is 188 crore, but the number may reduce if in future, single-dose vaccines are approved, the Centre said.
-
Single-Dose Sputnik Vaccine To Be Launched In India Soon: Russian Envoy
The single-dose Sputnik Light COVID-19 vaccine is expected to launch soon in India said Russian envoy Nikolay Kudashev on Wednesday.
-
India Will Accept 1-Dose Sputnik Light Trial Data From Russia: Dr Reddy's
A government expert panel has said that Sputnik Light can submit Phase 3 trial data for the single-dose Sputnik Light COVID-19 vaccine in India, its India-partner Dr Reddy's said on Thursday, hours after reports said they had been denied approval for
-
Cipla Close To Committing Over $1 Billion For Moderna Booster Vaccine In India: Report
Seeking fast-track approvals to bring Moderna's single-dose COVID-19 booster vaccine in India expeditiously, Cipla has requested the government for indemnification and exemptions from price capping, bridging trials and basic customs duty.
-
Centre Expects Speedy India Launch Of Single-Dose Sputnik Light: Report
The government is hopeful of a speedy launch of single-dose COVID-19 vaccine Sputnik Light in India and all stakeholders, including the Russian manufacturer and its Indian partners, have been directed to fast-track the application
-
Moderna, Pfizer Covid Vaccines Likely In India Next Year: Report
Moderna is expecting to launch a single-dose COVID-19 vaccine in India next year and is in talks with Cipla among other firms, while Pfizer is ready to offer 5 crore shots in 2021 but it wants significant regulatory relaxations.
-
J&J Seeks India's Permission For Phase 3 Trial Of 1-Shot Vaccine: Report
Multinational pharma giant Johnson & Johnson has applied to India's drug regulator seeking permission to conduct phase-3 clinical trial of its single-dose COVID-19 vaccine in India as well as import licence, sources said.
-
J&J Says In Talks With India For Clinical Study Of Single-Dose Vaccine
Johnson & Johnson says in talks with India to start early stage clinical study of its single-dose Covid vaccine
